LivaNova completes PRELUDE study for Caisson TMVR system
Medical technology company LivaNova has completed the PRELUDE feasibility study for its Caisson Transcatheter Mitral Valve Replacement (TMVR)…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Aug 18
Medical technology company LivaNova has completed the PRELUDE feasibility study for its Caisson Transcatheter Mitral Valve Replacement (TMVR)…
07 Aug 18
Biotechnology firm Cure Genetics, which is engaged in the development of life-saving transformative medicines and molecular diagnostics using…
07 Aug 18
Neovasc said treatment with its Reducer, a CE-Marked medical device designed for the treatment of refractory angina, was…
07 Aug 18
Antares Pharma, a company focused on the development and commercialization of self-administered parenteral pharmaceutical products using advanced drug…
06 Aug 18
Diagnostic ultrasound systems and probes manufacturer Esaote has launched MyLabX7, MyLabX6 and MyLabX5 ultrasound systems.
06 Aug 18
Neovasc has entered into a collaboration and licensing agreement relating to certain know-how developed by Penn Medicine and…
06 Aug 18
Science Exchange, a marketplace for outsourced R&Dk, has partnered with Reveal Biosciences to offer on-demand access to artificial…
06 Aug 18
JenaValve Technology has started the recruitment of patients in the early feasibility study (EFS) of its next generation…
06 Aug 18
Opko Health has completed recruitment of patients in its global phase 3 study of somatrogon (hGH-CTP) in growth…
03 Aug 18
Calcivis, a medical devices company focused on the management of tooth decay and enabling preventive dentistry, has closed…